Cargando…
A Case Report for Severe COVID-19 in a 9-Year-Old Child Treated with Remdesivir and Dexamethasone
Coronavirus disease 2019 (COVID-19) is generally milder in children than in adults, and a substantial proportion of children with the disease have asymptomatic infections. Remdesivir is recommended for severe COVID-19. To date, there are little data on the outcomes of remdesivir treatment in childre...
Autores principales: | Jo, Yoon Hee, Hwang, Yosub, Choi, Soo-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313394/ https://www.ncbi.nlm.nih.gov/pubmed/34313036 http://dx.doi.org/10.3346/jkms.2021.36.e203 |
Ejemplares similares
-
Dexamethasone/remdesivir: Acute pancreatitis: case report
Publicado: (2022) -
A Retrospective Study of Dexamethasone, Remdesivir, and Baricitinib in Severe COVID-19
por: Ngo, Dallis Q., et al.
Publicado: (2022) -
Dexamethasone/propofol/remdesivir: Various toxicities: case report
Publicado: (2021) -
Antibacterials/dexamethasone/remdesivir: Lack of efficacy: case report
Publicado: (2022) -
Dexamethasone/remdesivir/tocilizumab: Various toxicities: case report
Publicado: (2022)